Superworth

Kimberly-Clark KMB

Household & Personal Products, Consumer Defensive
$110.15
−1.93%
Market cap
$36.6B
PE
18.7×
10y median 21.4×
Forward PE
15.8×
10y median 19.4×
Price to sales
2.2×
EV/EBIT
16.7×
Revenue, 12 months
$16.6B
+1% on a year ago
Net margin
11.8%
Free cash flow yield
5.0%

Kimberly-Clark trades at 18.7× trailing earnings, cheaper than 79% of the last ten years. Revenue was $16.6B over the last twelve months, up 1% on a year earlier with a 12% net margin.

Charts

Financials

Income statement for KMB, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$5.1B+2%$5B+0%$4.3B−17%$4.2B−18%$4.1B−19%$4.1B−17%$4.1B−6%$4.2B−2%$4.2B+0%$4.1B−1%$4.2B+3%$4.2B+1%
Cost of revenue$3.3B−6%$3.2B−3%$3.2B−7%$2.6B−23%$2.6B−22%$3.3B+1%$2.5B−21%$2.7B+3%$2.7B+3%$2.6B−20%$2.6B+3%$2.6B−5%
Gross profit$1.8B+19%$1.7B+7%$1.7B−2%$1.6B−8%$1.6B−15%$1.4B−17%$1.5B−11%$1.5B−9%$1.5B−5%$1.5B+1%$1.5B+2%$1.6B+10%
$774M+18%$670M−6%$853M+8%$539M+377%$1B+33%$548M−18%$631M−26%$592M+10%$621M−40%$507M−8%$753M+19%$633M+7%
Interest expense$74M+1%$70M−8%$67M−8%$72M−5%$67M−10%$64M−9%$64M−5%$67M−7%$65M−3%$60M−6%$58M−9%$53M−21%
Pre-tax income$698M+23%$614M−1%$781M+11%$461M+11425%$962M+38%$479M−22%$557M−29%$513M+11%$546M−43%$436M−9%$685M+23%$572M+12%
$157M+24%$155M+12%$184M+6%$60M$187M+19%$71M−54%$131M−29%$116M+93%$248M+33%$104M+47%$164M+25%$217M+87%
Net income$587M+26%$509M+0%$647M+14%$544M+433%$907M+55%$447M−12%$567M−12%$509M−6%$446M−51%$499M+12%$665M+17%$345M−32%
$1.73+25%$1.50+0%$1.91+14%$1.61+437%$2.69+56%$1.34−11%$1.70−11%$1.53−5%$1.34−50%$1.50+12%$2.00+18%$1.04−32%
338.9M+0%338.8M+0%338.3M−0%338M−0%337.2M−1%334.3M−1%333.3M−2%333.3M−1%333.1M−1%333.2M−0%333.2M+0%333.3M+0%

EPS, diluted: 15 periods, Q2 FY09 to Q4 FY24: quarter's net income to common over its shares, to the cent. Q4 FY09: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'.

Diluted shares: Q1 FY09: not printed by the filing, worked out from its own lines. 16 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY14: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Estimates

Next earnings report: .

QuarterRevenueRangeEPSRangeAnalysts
Q3 FY26$4.1B$4.1B to $4.2B$1.63$1.55 to $1.719
Q4 FY26$4.1B$4.1B to $4.2B$1.65$1.59 to $1.709
Q1 FY27$4.2B$4.2B to $4.3B$1.81$1.78 to $1.836
Q2 FY27$4.3B$4.3B to $4.3B$1.91$1.88 to $1.933
Q3 FY27$4.2B$4.2B to $4.3B$1.78$1.76 to $1.803
Q4 FY27$4.3B$4.2B to $4.3B$1.81$1.78 to $1.836
Q1 FY28$8.4B$8.3B to $8.5B$1.91$1.88 to $1.938
Q2 FY28$8.6B$8.5B to $8.7B$2.08$2.05 to $2.104

Peers

Companies in Household & Personal Products nearest Kimberly-Clark's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
KMBKimberly-Clark$36.6B18.7×21.4×15.8×2.2×+1%11.8%
KVUEKenvue$37.6B22.5×24.1×16.2×2.4×+2%10.8%
ELEstée Lauder Companies$39.3B222×44.6×32.8×2.6×+5%1.2%
CHDChurch & Dwight$25B33.8×29.4×26.9×4.0×+3%12.0%
CLColgate-Palmolive$75B37.3×27.2×24.0×3.6×+5%9.7%
AVYAvery Dennison$13.8B19.9×23.4×n/m1.5×+6%7.6%
ELFe.l.f. Beauty$6.7B114×69.2×n/m3.8×+31%3.4%
REYNReynolds Consumer Products$4.9B14.0×17.6×n/m1.3×+3%9.1%
IPARInterparfums$3.7B22.0×30.4×n/m2.5×+3%11.2%
Peer median$19.4B28.2×28.3×25.5×2.5×+4%9.4%

More on Kimberly-Clark

Each number over time

Where it ranks

Its groups

About

Industry
Household & Personal Products
Sector
Consumer Defensive

Valuation data, not investment advice. Prices as of .